+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pulmonary Vascular Disease: From Bench to Bedside, An issue of Heart Failure Clinics. The Clinics: Internal Medicine Volume 22-3

  • Book

  • July 2026
  • Elsevier Health Science
  • ID: 6252591
In this issue of Heart Failure Clinics, guest editors Drs. Alberto Maria Marra and Pablo Demero-Rodriguez bring their considerable expertise to the topic of Pulmonary Vascular Disease: From Bench to Bedside. Top experts discuss follow-up of pulmonary embolism; impact of COVID-19 on pulmonary hypertension; pulmonary embolism and cancer; efficacy of exercise training in pulmonary vascular disease; and much more.
  • Contains 14 relevant, practice-oriented topics including new biomarkers in early prognosis in pulmonary embolism; application of machine learning and AI-based drug discovery in clinical management of pulmonary hypertension; sex/gender differences in pulmonary embolism; and more
  • Provides in-depth clinical reviews on pulmonary vascular disease: from bench to bedside, offering actionable insights for clinical practice
  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Authors

Alberto Maria Marra Associate Professor of Internal Medicine, Department of Translational Medical Sciences, "Federico II� University of Naples Attending Physician, Internal Medicine at the Metabolism and Rehabilitation Unit, Department of Internal Medicine and Clinical Complexity, "Federico II� University Hospital, Naples, Italy. Pablo Demelo-Rodr�guez Venous Thromboembolism Unit, Internal Medicine Department, Hospital General Universitario Gregorio Mara��n. Universidad Complutense de Madrid, Spain.